Skip to main content

Pfizer PGN 150 Pill - white capsule/oblong, 18mm

Generic Name: pregabalin

Pill with imprint Pfizer PGN 150 is White, Capsule/Oblong and has been identified as Lyrica 150 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Lyrica is used in the treatment of Neuropathic Pain; Fibromyalgia; Neuralgia; Diabetic Peripheral Neuropathy; Postherpetic Neuralgia and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Lyrica 150 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).

Images for Pfizer PGN 150

Lyrica 150 mg Pfizer PGN 150
Lyrica 150 mg Pfizer PGN 150
Lyrica 150 mg Pfizer PGN 150
Lyrica 150 mg Pfizer PGN 150
Lyrica 150 mg Pfizer PGN 150
Lyrica 150 mg Pfizer PGN 150

Lyrica

Generic Name
pregabalin
Imprint
Pfizer PGN 150
Strength
150 mg
Color
White
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Gamma-aminobutyric acid analogs
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
5 - Some potential for abuse
Labeler / Supplier
Pfizer U.S. Pharmaceuticals Group
Inactive Ingredients
lactose monohydrate, corn starch, magnesium silicate, titanium dioxide, sodium lauryl sulfate, silicon dioxide, shellac, ferrosoferric oxide, propylene glycol, potassium hydroxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00071-1016 Pfizer Inc.
54868-5456 (Discontinued) Physicians Total Care Inc. (repackager)
52959-0897 H.J. Harkins Company, Inc. (repackager)
35356-0054 Lake Erie Medical and Surgical Supply (repackager)
55289-0214 PDRX Pharmaceuticals Inc. (repackager)
68071-0389 Nucare Pharmaceuticals Inc. (repackager)
33261-0708 Aidarex Pharmacuticals, LLC (repackager)
54569-6336 (Discontinued) A-S Medication Solutions, LLC (repackager)
54569-8707 (Discontinued) A-S Medication Solutions, LLC (repackager)
68071-1356 Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related images for "Pfizer PGN 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.